For a biopharmaceutical company as large as Pfizer, achieving truly comprehensive supply chain visibility is a mammoth undertaking.

This year's first-place entrant, Intel, is huge — and problems there can be just as big.

In the race to lure companies looking for alternative sites amid the U.S.-China trade war, Vietnam wields a slew of advantages over its rivals.

U.S. firms operating in Asia are adapting to global trade uncertainty with a range of survival tactics, from reviewing how goods are classified to tweaking their supply chains.